Page 165 - MI-2-3

Microbes & Immunity Hyphae and healthspan

93. Gutowski Ł, Kanikowski S, Formanowicz D. Mast cell disease (AD ): A new molecular paradigm. Alzheimers
2
involvement in the pathogenesis of selected musculoskeletal Dement. 2022;19:1086-1098.
diseases. Life (Basel). 2023;13(8):1690.
doi: 10.1002/alz.12789
doi: 10.3390/life13081690 105. Mortensen, MB, Jensen, JM, Sand, NPR, et al. Association of
94. Sumantri S, Rengganis I. Immunological dysfunction and autoimmune diseases with coronary atherosclerosis severity
mast cell activation syndrome in long COVID. Asia Pac and ischemic events. J Am Coll Cardiol. 2024;83(25):2643-2654.
Allergy. 2023;13(1):50-53.
doi: 10.1016/j.jacc.2024.04.030
doi: 10.5415/apallergy.0000000000000022
106. Keyes E, Grinnell M, Jacoby D, et al. Assessment and
95. Monaco A, Choi D, Uzun S, Maitland A, Riley B. Association management of the heightened risk for atherosclerotic
of mast-cell-related conditions with hypermobile syndromes: cardiovascular events in patients with lupus erythematosus or
A review of the literature. Immunol Res. 2022;70(4):419-431. dermatomyositis. Int J Womens Dermatol. 2021;7(5A):560-575.
doi: 10.1007/s12026-022-09280-1 doi: 10.1016/j.ijwd.2021.08.015
96. Kohno R, Cannom DS, Olshansky B, et al. Mast cell 107. Popescu D, Rezus E, Badescu MC, et al. Cardiovascular
activation disorder and postural orthostatic tachycardia risk assessment in rheumatoid arthritis: Accelerated
syndrome: A clinical association. J Am Heart Assoc. atherosclerosis, new biomarkers, and the effects of biological
2021;10(17):e021002. therapy. Life (Basel). 2023;13(2):319.
doi: 10.1161/JAHA.121.021002 doi: 10.3390/life13020319
97. Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in 108. Jin T, Huang W, Cao F, et al. Causal association between
the joint hypermobility syndrome. Am J Med. 2003;115:33-40. systemic lupus erythematosus and the risk of dementia:
A mendelian randomization study. Front Immunol.
doi: 10.1016/S0002-9343(03)00235-3
2022;13:1063110.
98. Wang Y, Wang T, Cai M, Zhu S, Song L, Wang Q. Expression
and existence forms of mast cell activating molecules and doi: 10.3389/fimmu.2022.1063110
their antibodies in systemic lupus erythematosus. Immun 109. Kodishala, C, Hulshizer, CA, Kronzer, VL, et al. Risk
Inflamm Dis. 2022;10(2):235-240. factors for dementia in patients with incident rheumatoid
arthritis: A population-based cohort study. J Rheumatol.
doi: 10.1002/iid3.567
2023;50(1):48-55.
99. Gumà M, Olivé A, Roca J, et al. Association of systemic doi: 10.3899/jrheum.220200
lupus erythematosus and hypermobility. Ann Rheum Dis.
2002;61:1024-1026. 110. Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks
of cancer development in Systemic Lupus Erythematosus
doi: 10.1136/ard.61.11.1024
(SLE) patients: A systematic review and meta-analysis.
100. Shaw BH, Stiles LE, Bourne K, et al. The face of postural Arthritis Res Ther. 2018;20:270.
tachycardia syndrome - insights from a large cross- doi: 10.1186/s13075-018-1760-3
sectional online community-based survey. J Intern Med.
2019;286(4):438-448. 111. Beydon M, Pinto S, De Rycke Y, et al. Risk of cancer for
patients with rheumatoid arthritis versus general population:
doi: 10.1111/joim.12895
A national claims database cohort study. Lancet Reg Health
101. Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Eur. 2023;35:100768.
Anticardiolipin antibodies in systemic lupus erythematosus:
Clinical and laboratory correlations. Am J Med. doi: 10.1016/j.lanepe.2023.100768
1995;99(6):624-628. 112. Zamani M, Ebrahimtabar F, Alizadeh-Tabari S, et al. Risk
of common neurological disorders in adult patients with
doi: 10.1016/s0002-9343(99)80249-6
inflammatory bowel disease: A systematic review and meta-
102. Meroni PL, Tsokos GC. Editorial: Systemic lupus analysis. Inflamm Bowel Dis. 2024;30:2195-2204.
erythematosus and antiphospholipid syndrome. Front doi: 10.1093/ibd/izae012
Immunol. 2019;10:199.
113. Bozza S, Fallarino F, Pitzurra L, et al. A crucial role for
doi: 10.3389/fimmu.2019.00199
tryptophan catabolism at the host/Candida albicans
103. Mangani D, Yang D, Anderson AC. Learning from the nexus interface. J Immunol. 2005;174(5):2910-2918.
of autoimmunity and cancer. Immunity. 2023;56(2):256-271.
doi: 10.4049/jimmunol.174.5.2910
doi: 10.1016/j.immuni.2023.01.022
114. Eroğlu İ, Eroğlu BÇ, Güven GS. Altered tryptophan
104. Weaver DF. Alzheimer’s disease as an innate autoimmune absorption and metabolism could underlie long-term

Volume 2 Issue 3 (2025) 157 doi: 10.36922/mi.4736